Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2026-01-09 00:00:00 ET · period of report 2026-01-07 · accession 0001673528-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-09 | 2026-01-07 | ANAB | Faga Daniel | Pres, CEO, Dir | M - OptEx | — | +26.8K | 493.6K | +6% | — |
| D | 2026-01-09 | 2026-01-08 | ANAB | Faga Daniel | Pres, CEO, Dir | S - Sale+OE | $44.71 | -14.3K | 479.3K | -3% | -$638.5K |
| D | 2026-01-09 | 2026-01-07 | ANAB | Faga Daniel | Pres, CEO, Dir | M - OptEx | $0.00 | -26.8K | 80.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-07 | M | A | 26,838 | — | 493,625 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 2 | Common | Common Stock | 2026-01-08 | S | D | 14,281 | $44.71 | 479,344 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-01-07 | M | D | 26,838 | $0.00 | 80,512 | D | — · — to — | 26,838 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F3) The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |